Although sample sizes are much smaller, results from studies of human tissue from early and late-onset AD corroborate with those obtained from disease models to strengthen the case for CaN hyper-activation as a central factor in AD pathogenesis in both sporadic and familial AD pathogenesis. Here, NUP214 is linked to Alzheimer disease.